Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
The fact that the FBI has lost its way has been on public display for at least five years now. Truth be told, it probably strayed off course way before that. But during the Trump Presidency, it became too obvious to ignore.
House Minority Leader Kevin McCarthy (R-CA) plans to launch at least seven investigations into Democrat President Joe Biden’s administration if Republicans win back control of the House of Representatives in 2022, which is expected.
Nicholas Sandmann announced he has reached a settlement with NBCUniversal after more than two years since Sandmann filed a defamation lawsuit against the media company.
Amid concerns about Beijing's use of emerging technologies, the administration adds China's top military medical research institute to an export blacklist.
Forty conservative leaders called for the immediate expulsion of the two "Never Trump" representatives for serving on Speaker Pelosi's Jan. 6 select committee.
Dr. Marty Makary, a public health researcher at Johns Hopkins Bloomberg School of Public Health, on Tuesday accused government officials of practicing “modern-day McCarthyism” against anyone who suggests young healthy people, especially those who recovered from COVID, don’t need booster shots.
Any Immigration and Customs Enforcement officer who wants to arrest an illegal immigrant in the District of Columbia will have to hope the target is sunning in Rock Creek Park or rowing on the Anacostia River.
